medline.ch Onkologie Urologische Tumoren

	Robot-assisted partial nephrectomy for hilar versus non-hilar renal tumors: a systematic review and meta-analysis. J Robot Surg Luo J, Gu W, Li W, Chen P, Yu Q, Zhong S, Li T, Sun F. PMID: 41699371 [PubMed - indexed for MEDLINE]
	Correction: A Novel Model for Muscle-Invasive Bladder Cancer Diagnosis Using Contrast-Enhanced Ultrasound. Ann Surg Oncol Liu Q, Lu X, He C, Chen J, He M, Zhang S, Zhu Y, Wu J, Hu B, Huang J. PMID: 41699356 [PubMed - as supplied by publisher]
	Digital pathology-based artificial intelligence algorithms in prostate cancer: inside the 'black box'. BJU Int de la Calle CM, Baras AS, Lotan TL. PMID: 41698677 [PubMed - as supplied by publisher]
	[Healthcare Research in Renal Cell Cancer: 7-Year-Data from the VERSUS Study by d-uo]. Aktuelle Urol Johannsen M, Eichenauer R, Klier J, König F, Schönfelder R, Schröder J, Hempel E, Doehn C. PMID: 41698400 [PubMed - as supplied by publisher]
	Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical Prostatectomy. J Natl Compr Canc Netw Nikitas J, Smith CP, Armstrong WR, Murthy V, Grogan T, Clark K, Moore J, Roberts M, Farolfi A, Reiter RE, Rettig MB, Shen J, Valle LF, Nickols NG, Steinberg ML, Czernin J, Kishan AU, Calais J. PMID: 41698328 [PubMed - indexed for MEDLINE]
	Renal-vascular axis: unmasking its role in vascular endothelial growth factor-inhibitor vascular toxicity in cancer patients. Br J Pharmacol Whelan G, Neves KB. PMID: 41698318 [PubMed - as supplied by publisher]
	Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison. Cancer Rep (Hoboken) Chen W, Yoshida S, Fujii Y. PMID: 41697957 [PubMed - indexed for MEDLINE]
	CT-based subregional and peritumoral radiomics for predicting pathological T stage of clear cell renal cell carcinoma: an exploratory study of biological mechanisms. Insights Imaging Huang JL, Liu Q, Wang CL, Lang X, Zeng YX, Zhou DQ. PMID: 41697559 [PubMed]
	Oncologic outcomes after robot assisted radical cystectomy in patients with clinically positive lymph nodes (cN1): a tertiary referral center experience. Minerva Urol Nephrol Lambertini L, Saladino M, DI Maida F, Grosso AA, Carli G, Lipparini F, Conte F, Cadenar A, Possanzini S, DI Stefano L, Lo Re M, Oriti R, Fantechi R, Vittori G, Mari A, Minervini A. PMID: 41697211 [PubMed - indexed for MEDLINE]
	Sutureless robotic-assisted partial nephrectomy: a propensity score-matched analysis (UroCCR N.158). Minerva Urol Nephrol Blanco A, Margue G, Yacoub M, Klein C, Estrade V, Alezra É, Capon G, Bladou F, Robert G, Bernhard JC. PMID: 41697210 [PubMed - indexed for MEDLINE]
	Three-dimensional virtual model for robot-assisted partial nephrectomy in totally endophytic renal tumors: a propensity-score matching analysis with a control group. Minerva Urol Nephrol Grosso AA, DI Maida F, Lambertini L, Carli G, Saladino M, Conte FL, Salamone V, Conte F, Kucuku N, Lipparini F, Paganelli D, Giudici S, Oriti R, Fantechi R, Salvi M, Vittori G, Minervini A, Mari A. PMID: 41697206 [PubMed - indexed for MEDLINE]
	Contemporary methods for surgical margin assessment in radical prostatectomy: a systematic review and meta-analysis of diagnostic test accuracy. Minerva Urol Nephrol Gaya JM, Tomczak W, Verri P, Gallioli A, Avesani G, DI Bello F, Mas L, Huguet J, Krajewski W, Palou J, Breda A. PMID: 41697203 [PubMed - indexed for MEDLINE]
	The Italian Society of Urology Statement on focal therapy for localized prostate cancer. Minerva Urol Nephrol Lughezzani G, Celia A, Fasulo V, Marra G, Silvestri T, Vittori G, Stabile A, Mastroianni R, Branchi A, Falagario U, Simone G, Bove P, Iacovelli V, DE Luca S, Ficarra V, Minervini A, Salonia A, Mirone V, Carrieri G, Buffi NM, Lazzeri M, SIU. PMID: 41697201 [PubMed - indexed for MEDLINE]
	Efficacy and safety of tripleÂ or dual therapies for metastatic hormone-sensitive prostate cancer: a systematic review and Bayesian network meta-analysis. Future Oncol Jiang J, Wang Y, Bai J, Yang G, Wang H, Ding H, Zhang Y, Zhai Z, Dong Z, Wang Z. PMID: 41697112 [PubMed - indexed for MEDLINE]
	Impact of Cytoreductive Nephrectomy on Immune Checkpoint Inhibitor Therapy: Treatment Outcomes of Immune Inhibitors Combination Therapies for Metastatic Renal Cell Carcinoma With Primary Kidney Tumors. Int J Urol Nemoto Y, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Shimmura H, Hashimoto Y, Kondo T, Kobayashi H, Takagi T. PMID: 41696929 [PubMed - indexed for MEDLINE]
	Effect of extending the oral administration period of 5-aminolevulinic acid on diagnostic accuracy and treatment outcomes for non-muscle-invasive bladder cancer. BJUI Compass Fukuhara H, Shigehisa R, Yamamoto S, Fukata S, Saito K, Shibanaka Y, Inoue K. PMID: 41696653 [PubMed]
	Psychological distress among bladder cancer patients: A systematic review. Urol Ann Indraswari MT, Rahman F, Hamid ARAH, Mochtar CA. PMID: 41696616 [PubMed]
	Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review. Front Oncol Prada NJ, Mendivelso-González D, Yepes S, Corredor C, Parra-Medina R, Varela R, Serrano ML. PMID: 41695345 [PubMed]
	A nomogram based on the red cell distribution width to lymphocyte ratio as a prognostic tool for non-muscle-invasive bladder cancer: a retrospective study. Front Oncol Song F, Su S, Zhang X, Cao Y, Cui X, Zhang L, Li C, Li S, Tian S, Liu L. PMID: 41695338 [PubMed]
	An explainable machine learning model for predicting bladder tumor aecurrence risk. Front Oncol Wu S, Wang Y, He J, Peng W, Hu W. PMID: 41695336 [PubMed]

Artikel 1 - 20 / 176053

Seite 1 von 8803

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung